---
figid: PMC6032063__zh30041874340002
figlink: /pmc/articles/PMC6032063/figure/F0002/
number: Fig. 2
caption: Biliverdin reductase signaling reduces hepatic fat accumulation. Biliverdin
  reductase A (BVRA) generation of unconjugated bilirubin from biliverdin activates
  peroxisome proliferator-activated receptor-α (PPARα; ), which is a transcription
  factor that interacts with the retinoid X receptor (RXR) to increase genes in the
  β-oxidation pathway that burn fatty acids in the mitochondria. BVRA activates Akt,
  which inhibits glycogen synthase kinase-3β (GSK3β) through increased phosphorylation
  at serine 9 (S9) to prevent hepatic steatosis (). BVRA can also directly interact
  with GSK3β to regulate activity (). Inhibition of GSK3β results in increased activity
  of PPARα via decreased phosphorylation (P) at serine 73 (). Z, zinc finger DNA binding
  domains. The signaling functions of BVRA and bilirubin have been reviewed further
  by Hamoud et al. (), O’Brien et al. (), and Rochette et al. ().
pmcid: PMC6032063
papertitle: Biliverdin reductase and bilirubin in hepatic disease.
reftext: Lauren Weaver, et al. Am J Physiol Gastrointest Liver Physiol. 2018 Jun 1;314(6):G668-G676.
pmc_ranked_result_index: '55058'
pathway_score: 0.9662674
filename: zh30041874340002.jpg
figtitle: Biliverdin reductase signaling reduces hepatic fat accumulation
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6032063__zh30041874340002.html
  '@type': Dataset
  description: Biliverdin reductase signaling reduces hepatic fat accumulation. Biliverdin
    reductase A (BVRA) generation of unconjugated bilirubin from biliverdin activates
    peroxisome proliferator-activated receptor-α (PPARα; ), which is a transcription
    factor that interacts with the retinoid X receptor (RXR) to increase genes in
    the β-oxidation pathway that burn fatty acids in the mitochondria. BVRA activates
    Akt, which inhibits glycogen synthase kinase-3β (GSK3β) through increased phosphorylation
    at serine 9 (S9) to prevent hepatic steatosis (). BVRA can also directly interact
    with GSK3β to regulate activity (). Inhibition of GSK3β results in increased activity
    of PPARα via decreased phosphorylation (P) at serine 73 (). Z, zinc finger DNA
    binding domains. The signaling functions of BVRA and bilirubin have been reviewed
    further by Hamoud et al. (), O’Brien et al. (), and Rochette et al. ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - RXRA
  - AKT1
  - RXRG
  - GSK3B
  - AKT3
  - RXRB
  - PPARA
  - biliverdin
  - bilirubin
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRA
  entrez: '6256'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRG
  entrez: '6258'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRB
  entrez: '6257'
- word: PPARA
  symbol: PPARA
  source: hgnc_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
chemicals:
- word: biliverdin
  source: MESH
  identifier: D001664
- word: bilirubin
  source: MESH
  identifier: D001663
diseases: []
---
